GSK announced that the European Commission has approved Exdensur (depemokimab) [...]

ViiV Healthcare will present new data from its long-acting and [...]

Compass Pathways has reported that its second pivotal Phase 3 [...]

Boehringer Ingelheim has reported Phase 2 clinical trial results showing [...]

Scancell Holdings has announced that the U.S. Food and Drug [...]

Bicara Therapeutics has selected 1500 mg of ficerafusp alfa as [...]

Doron Therapeutics has dosed the first patients in its Phase [...]

Enterome has received Fast Track designation from the US Food [...]

Cidara Therapeutics has announced an expanded and accelerated Phase 3 [...]

AstraZeneca has reported positive interim results from the Phase 3 [...]